Design Therapeutics Inc (DSGN)
4.57
-0.20
(-4.19%)
USD |
NASDAQ |
May 10, 16:00
4.59
+0.02
(+0.44%)
After-Hours: 20:00
Design Therapeutics Shareholders Equity (Quarterly): 277.69M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 277.69M |
| September 30, 2023 | 284.96M |
| June 30, 2023 | 296.80M |
| March 31, 2023 | 312.82M |
| December 31, 2022 | 327.31M |
| September 30, 2022 | 340.94M |
| June 30, 2022 | 357.16M |
| Date | Value |
|---|---|
| March 31, 2022 | 370.31M |
| December 31, 2021 | 382.13M |
| September 30, 2021 | 391.56M |
| June 30, 2021 | 401.60M |
| March 31, 2021 | 408.01M |
| December 31, 2020 | -11.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.32M
Minimum
Dec 2020
408.01M
Maximum
Mar 2021
318.46M
Average
340.94M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Biogen Inc | 15.21B |
| PTC Therapeutics Inc | -893.92M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 289.64M |
| Total Liabilities (Quarterly) | 11.96M |